ANDA 89209, held by Par Pharm. Methylprednisolone.
As of Nov 16, 2026, ANDA 89209 (Methylprednisolone), held by Par Pharm, was first approved by FDA on Apr 25, 1988, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 25, 1988 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Methylprednisolone32MG ยท tablet;oral | Methylprednisolone | Discontinued |
| Jun 7, 1996 | Supplement 3Manufacturing | Approved | None posted |
| Mar 9, 1995 | Supplement 2Labeling | Approved | None posted |
| Apr 29, 1994 | Supplement 1Labeling | Approved | None posted |
| Apr 25, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters